Literature DB >> 1182196

Isolation and characterization of undersulphated chondroitin-4-sulphate from normal human plasma.

M Juvani, C Friman, H Ranta, O Wegelius.   

Abstract

The present study was undertaken in order to characterize further the glycosaminoglycans of normal human plasma. Coagulation factor IX concentrate prepared from undiluted plasma by DEAE-Sephadex chromatography was used as the starting material. The concentrate was subjected to proteolytic treatment with papain and pronase, deproteinised with trichloroacetic acid, dialysed and passed through an AG 1 X 2 anion-exchange column. Glycosaminoglycans were eluted stepwise from the column with NaC1. The sole glycosaminoglycan obtained was an undersulphated chondroitin-4-sulphate which was identified by chemical analyses, digestibility with testicular hyaluronidase, electrophoretic behaviour and infrared spectrum. Gel-exclusion chromatography indicated a molecular weight of 17 000 for the compound. The undersulphated chondroitin-4-sulphate was calculated to represent at least 80% of the macromolecular glycosaminoglycans present in normal human plasma and to occur in a concentration of approx. 3 mg hexuronate per 1 of plasma.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1182196     DOI: 10.1016/0304-4165(75)90279-2

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  5 in total

1.  Plasmatic and Urinary Glycosaminoglycans Characterization in Mucopolysaccharidosis II Patient Treated with Enzyme-Replacement Therapy with Idursulfase.

Authors:  Giovanni V Coppa; Dania Buzzega; Lucia Zampini; Francesca Maccari; Lucia Santoro; Fabio Galeotti; Tiziana Galeazzi; Orazio Gabrielli; Nicola Volpi
Journal:  JIMD Rep       Date:  2011-11-04

2.  Isolation and characterization of glycosaminoglycans in human plasma.

Authors:  I Staprans; J M Felts
Journal:  J Clin Invest       Date:  1985-11       Impact factor: 14.808

3.  Purification and characterization of human platelet proteoglycan.

Authors:  M Okayama; K Oguri; Y Fujiwara; H Nakanishi; H Yonekura; T Kondo; N Ui
Journal:  Biochem J       Date:  1986-01-01       Impact factor: 3.857

4.  Analysis of glycosaminoglycans in human serum after oral administration of chondroitin sulfate.

Authors:  A Baici; D Hörler; B Moser; H O Hofer; K Fehr; F J Wagenhäuser
Journal:  Rheumatol Int       Date:  1992       Impact factor: 2.631

5.  Plasmatic kinetics of dermatan sulfate during enzyme replacement therapy with iduronate-2-sulfatase in a mucopolysaccharidosis II patient.

Authors:  Nicola Volpi; Lucia Zampini; Francesca Maccari; Lucia Santoro; Fabio Galeotti; Tiziana Galeazzi; Orazio Gabrielli; Giovanni V Coppa
Journal:  Glycoconj J       Date:  2013-03-20       Impact factor: 2.916

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.